Industry Advocacy

WASHINGTON — Target CEO on Tuesday testified before a House of Representatives committee to discuss why the proposed Border Adjustment Tax, which taxes imports 20% while exempting exports, is a bad idea.

"Under the new border adjustment tax, American families — your constituents — would pay more so many multinational corporations can pay even less," he testified.

BENTONVILLE, Ark. — Walmart  is stepping up its commitment to its workers who serve in the military by covering the difference when an employee's military salary is less than what the person makes working at the store.

ALEXANDRIA, Va. — The National Community Pharmacy on Monday submitted its comments to the House Ways and Means Health Subcommittee, suggesting how to improve access to prescription drugs and essential health services for Medicare beneficiaries. The organization, writing on behalf of the roughly 22,000 independent community pharmacy owners, highlighted pharmacy’s role in facilitating patient healthcare access.

NEW YORK — The Food and Drug Administration is reorganizing its field team within the FDA’s Office of Regulatory Affairs with a new focus on specific product areas vs. oversight of activities based on geographic regions, Bloomberg reported Monday.

ALEXANDRIA, Va. – The National Community Pharmacists Association on Thursday urged Senate Republicans to keep a number of important prescription drug-related provisions as they consider House passage of H.R. 1628, the American Health Care Act.

“Prescription drug coverage is an essential health benefit,” stated Douglas Hoey, CEO NCPA. “Any meaningful drug coverage should include patient choice of pharmacy and access to face-to-face counseling with a community pharmacist they know and trust.”

WASHINGTON — Mars Chocolate North America and Wrigley U.S. have announced a new commitment to creating health and well-being standards for consumers by working with the Partnership for a Healthier America and such other industry players as Nestle, Lindt, Ferrero to center the efforts on offering transparency and choice to consumers.

WASHINGTON — An amendment to improve generic drug competition has been approved as part of the Food and Drug Reauthorization Act, U.S. Sen. Susan Collins (R-Maine) told The Associated Press.

Collins said the amendment was approved May 11 at a Senate Health, Education, Labor and Pensions Committee business meeting, adding the measure is part of an investigation into "aggressive price hikes" in prescription drugs, and it will improve generic drug competition to help make prices lower.

WASHINGTON — By a vote of 57 to 42 (with one Senator not voting), the Senate on Tuesday confirmed the nomination of Scott Gottlieb, of Connecticut, to be commissioner of the Food and Drug Administration, Department of Health and Human Services